A new report from Boston Analytics titled "An Introduction to the Indian Pharmaceutical Industry" examines the factors that will lead to tremendous growth in the India pharmaceutical industry. This includes elements that will lead to a 13.5 percent compound annual growth rate (CAGR) in domestic production and sales of Active Pharmaceutical Ingredients (API) and generic drugs by 2010 as well as the booming Indian pharmaceutical outsourcing market that is expected to see a 37.5 percent CAGR in that same time span.
Boston, Mass., (PRWeb) October 31, 2007 -- Customized knowledge services company Boston Analytics today released its new report examining the vast economic opportunities in the pharmaceutical market in India. Titled "An Introduction to the Indian Pharmaceutical Industry," the report examines the elements that will lead to a 13.5 percent compound annual growth rate (CAGR) in domestic production and sales of Active Pharmaceutical Ingredients (API) and generic drugs by 2010 as well as the booming Indian pharmaceutical outsourcing market that is expected to see a 37.5 percent CAGR in that same time span.
"In the last few years, a lot of attention has been paid to the rapid growth of the software and manufacturing sectors in India. However, other industries are taking off in the region," said Rashid Bilimoria, CEO and Co-Founder, Boston Analytics. "This report illustrates the enormous potential of one of those markets - pharmaceuticals."
The report features a full section detailing the factors leading to the aforementioned internal demand for drugs, including the country's increasing population, an ever-expanding consumer base in the middle and upper income brackets, the need for improved healthcare infrastructure and Indian companies' reverse-engineering skills. Boston Analytics forecasts the domestic market to reach $10.3 billion by 2010.
The report then examines the Indian outsourcing market in the context of the global pharmaceutical landscape delving into sub-categories of growth including Contract Resource Outsourcing, Contract Manufacturing Outsourcing and other services. India also possesses 75 FDA-approved pharmaceutical plants - the largest number located in any country outside the United States. The report estimates India's pharmaceutical outsourcing market to hit $3.3 billion in the next two years.
With offices in the US and India, Boston Analytics is uniquely positioned to quantify the affects of increasing cooperation between the North American and Asia-Pacific economies.
"As a provider of knowledge services, we are always looking to uncover new areas of growth and illuminate new investment opportunities," said Bilimoria. "This report embodies this mission by crystallizing business opportunities with hard data."
"An Introduction to the Indian Pharmaceutical Industry" can be found at http://www.bostonanalytics.com/leading_thoughts_research/ba_indian_pharmaceutical_market_research_report_10_07.pdf
About Boston Analytics
Boston Analytics provides its corporate, consulting and financial clients the most current, accurate, and actionable research and analytics - so they can be first to uncover and exploit opportunities. The firm's work powers knowledge processes and enables effective decisions at all levels of our clients' businesses. Boston Analytics brings together leading analytical minds worldwide, delivers a robust offering of knowledge services, and works as genuine partners.
Boston Analytics delivers enterprise-wide knowledge advantage by providing fully customized knowledge services as well as flexible, preconfigured knowledge products and repositories. All knowledge services and products are tailored to meet the specific needs of corporations, consulting companies, and financial services firms.
Boston Analytics is headquartered in Boston with offices in New York, London, and Mumbai. More information can be found at www.bostonanalytics.com.